Matthew D Dallas Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Matthew D Dallas.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew D Dallas. Matthew D Dallas is a Chief Financial Officer in AVEO PHARMACEUTICALS INC ($AVEO) and a VP, Finance in AVEO PHARMACEUTICALS INC ($AVEO) and a Chief Financial Officer in CoLucid Pharmaceuticals, Inc. ($CLCD) and a Director in Biostage, Inc. ($BSTG).
Address: C/O AVEO PHARMACEUTICALS, INC. 650 E. KENDALL STREET CAMBRIDGE 02142 MA
Companies in which Matthew D Dallas is an Insider
AVEO PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew D Dallas: Chief Financial Officer, VP, Finance
Holdings: 14,506 shares
Current Value: $8,849
Latest Transaction: Feb 08 2019
$AVEO Market Capitalization: $45.51M
$AVEO Previous Close: $0.61
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Biostage, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Matthew D Dallas: Director
Holdings: 0 shares
Latest Transaction: Jun 05 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CoLucid Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew D Dallas: Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 01 2017
$CLCD Market Capitalization: $893.98M
$CLCD Previous Close: $46.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Matthew D Dallas
Sentiment: All, AVEO, BSTG, CLCD
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 05 2019 | BSTG | Biostage, Inc. | Dallas Matthew D | Director | Option Exercise | A | 2.90 | 8,411 | 24,392 | 18,775 | |
| Jun 05 2019 | BSTG | Biostage, Inc. | Dallas Matthew D | Director | Option Exercise | A | 2.90 | 10,364 | 30,056 | 10,364 | |
| Feb 08 2019 | AVEO | AVEO PHARMACEUTICA ... | Dallas Matthew D | Chief Financial Off ... | Option Exercise | A | 0.62 | 450,750 | 279,465 | 450,750 | |
| Nov 15 2018 | BSTG | Biostage, Inc. | Dallas Matthew D | Director | Option Exercise | A | 2.75 | 10,897 | 29,967 | 10,897 | |
| Feb 02 2018 | AVEO | AVEO PHARMACEUTICA ... | Dallas Matthew D | Chief Financial Off ... | Option Exercise | A | 3.08 | 250,000 | 770,000 | 250,000 | |
| Jul 05 2017 | AVEO | AVEO PHARMACEUTICA ... | Dallas Matthew D | Chief Financial Off ... | Option Exercise | A | 2.22 | 500,000 | 1,110,000 | 500,000 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Dallas Matthew D | Chief Financial Off ... | Option Exercise | D | 6.75 | 37,500 | 253,125 | 0 |